PU.1 Mutations and B-cell Acute Lymphoblastic Leukaemia
Author Information
Author(s): Mueller B U, Pabst T, Hauser P, Gilliland G, Neuberg D, Tenen D G
Primary Institution: University Hospital, Bern, Switzerland
Hypothesis
PU.1 mutations might contribute to the development of acute leukaemias of the B-cell lineage.
Conclusion
The study found no genomic alterations of the PU.1 gene in patients with B-cell acute lymphoblastic leukaemia, suggesting that PU.1 mutations are not common in this condition.
Supporting Evidence
- The study screened 62 patients with B-cell acute lymphoblastic leukaemia for PU.1 mutations.
- No genomic alterations of the PU.1 gene were found in the patients.
- The absence of PU.1 mutations in ALL contrasts with previous findings in AML patients.
Takeaway
The researchers looked for changes in a gene called PU.1 in kids and adults with a type of blood cancer but found none, meaning this gene isn't usually messed up in that cancer.
Methodology
The study screened 62 patients with B-cell acute lymphoblastic leukaemia for PU.1 mutations using direct sequencing of all five exons of the PU.1 gene.
Limitations
The study cannot exclude a low incidence of mutations in some specific subtypes of ALL due to the limited number of patients of each subtype.
Participant Demographics
The study included 62 patients with B-cell acute lymphoblastic leukaemia, with a male/female ratio of 40/22 and an age range of 1–62 years.
Statistical Information
Confidence Interval
90% upper confidence bound of 3.64%
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website